This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Del Zoppo, G. J. Articles by Harker, L. A. Search for Related Content PubMed PubMed Citation Articles by Del Zoppo, G. J. Articles by Harker, L. A. Pubmed/NCBI databases Substance via MeSH

Stroke, Vol 17, 638-643, Copyright © 1986 by American Heart Association

ARTICLES

The beneficial effect of intracarotid urokinase on acute stroke in a baboon model

GJ Del Zoppo, BR Copeland, TA Waltz, J Zyroff, EF Plow and LA Harker

The capacity of intracarotid infusion of urokinase to salvage neurologic function in a baboon model of acute thrombotic stroke has been studied. The model consists of reversible eccentric balloon compression (3 hours) of the right middle cerebral artery (MCA) proximal to the take-off of the lenticulostriate arteries (LSA), resulting in in situ thrombosis of perforating branches supplying the right corpus striatum. Neurologic endpoints included quantitative assessment of neurologic function (NE), estimation of cerebral infarction volume by computerized tomographic (CT) scan, and carotid angiography. In untreated acute stroke control animals (n = 6), a persistent decrease in functional score (from 100 to 36 +/- 11) at 14 days and a defined region of cerebral infarction (volume = 3.2 +/- 1.5) were detected at 10 days. Intracarotid urokinase administered to five animals (1.2 X 10(6) IU over 60 min) following the 3 hour period of MCA occlusion improved neurologic function (NE = 50, 55, 85, 100, 100) and reduced infarction size (0.3, 0.5, 0.8, 0.7, 1.1 cm3, respectively) without evidence of intracranial hemorrhage. Systemic fibrinogenolysis was produced in all five treated animals. We conclude that thrombolytic therapy given within 3 hours of experimental thrombotic occlusion may salvage neurologic function and reduce cerebral infarction volume without CT scan detectable intracranial bleeding.

This article has been cited by other articles:

				A C Pereira, P J Martin, and E A Warburton Thrombolysis in acute ischaemic stroke Postgrad. Med. J., March 1, 2001; 77(905): 166 - 171. [Full Text]

				J. G. Frazee, X. Luo, G. Luan, D. S. Hinton, D. A. Hovda, M. S. Shiroishi, L. T. Barcliff, and H. A. Kontos Retrograde Transvenous Neuroperfusion: A Back Door Treatment for Stroke • Editorial Comment Stroke, September 1, 1998; 29(9): 1912 - 1916. [Abstract] [Full Text] [PDF]

				L. R. Wechsler Analytic Reviews : Potential New Therapies for Acute Ischemic Stroke J Intensive Care Med, September 1, 1988; 3(5): 258 - 264. [Abstract] [PDF]